In a model of colitis induced in mice by intracolonic administration of dinitrobenzene sulphonic acid (DNBS), CBG was able to reduce colon weight/colon length ratio, myeloperoxidase activity and exerts an anti-inflammatory activity associated to DNBS administration. This evidence concerns the gene MPO and colitis.